Post

New research · Ophthalmology
Orbit (Amsterdam, Netherlands) · 2d
StudyOrbit (Amsterdam, Netherlands) · 2026

Study of the toxic effect of benzalkonium chloride on epithelial cells of the lacrimal canaliculi.

Anastasia M Subbot, Eugenia L Atkova, Anna D Panova, Vasily D Yartsev
Read paper
OphthalmologyStudy

Benzalkonium chloride's half-lethal dose for tear-duct lining cells was 21.02 µg/mL

Study of the toxic effect of benzalkonium chloride on epithelial cells of the lacrimal canaliculi.

Anastasia M Subbot … Vasily D Yartsev
Orbit (Amsterdam, Netherlands) · 2026
Purpose

The study aimed to investigate the cytotoxic effect of benzalkonium chloride on human lacrimal canalicular epithelial cells under both constant and dynamically decreasing concentrations, which more accurately reflects real ocular surface conditions after eye drop instillation.

Methods

This in vitro study was conducted at the Krasnov Research Institute of Eye Diseases.

Results
21.02 µg/mL
less benzalkonium chloride-killed tear-duct cells with gradual dilution than constant exposure
More results

When dynamically decreasing concentrations were used (mimicking physiological dilution), the cytotoxic effect was significantly reduced compared to constant concentration exposure at equivalent time points ( p < 0.05, two-way ANOVA).

“
Conclusion · 1 of 2

The dynamically decreasing concentration model, which better reflects in vivo conditions, demonstrates that physiological dilution of benzalkonium chloride in tear fluid significantly reduces its cytotoxic effect on lacrimal canalicular cells undergoing partial EMT.

Conclusion · 2 of 2

These findings support the hypothesis that dry eye syndrome and impaired tear drainage - conditions that prolong benzalkonium chloride exposure and may promote EMT - increase the risk of secondary lacrimal drainage obstruction in patients receiving long-term benzalkonium chloride-preserved therapy.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving